Indications

Dosage

One liter deworms 43,478 lb. of cattle; one gallon deworms 164,565 lb. of cattle. (2.33 mL/100 lb. of cattle).

BEEF AND DAIRY CATTLE: Administer orally by suitable dosing syringe. Insert nozzle of syringe through the interdental space and deposit the drug on the back of the tongue by depressing the plunger. The drug may also be administered by stomach tube.

EXAMPLES:

Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

Shake well before use.

Withdrawal Periods and Residue Warnings

Milk taken from cows during treatment and for 48 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 8 days following last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves.

Supplied

1,000 mL (33.8 fl. oz.)

Active Ingredient

Fenbendazole

Storage

Store at or below 25° C (77° F). Protect from freezing.

Warnings

NOT FOR USE IN HUMANS. KEEP OUT OF REACH OF CHILDREN.
The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or http://www.fda.gov/reportanimalae.

Other Warnings

Do not use in horses intended for human consumption. Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

CONSULT YOUR VETERINARIAN FOR ASSISTANCE IN THE DIAGNOSIS, TREATMENT AND CONTROL OF PARASITISM.

Contact

U.S. only: Merck Animal Health
The Safety Data Sheet (SDS) contains more detailed occupational safety information.
For customer service or to request a copy of the SDS, please call 1-800-521-5767 or email directsupport@merck.com.
For product questions or to report an adverse event, call 1-800-211-3573 or contact us.
For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, http://www.fda.gov/reportanimalae.
For more information regarding efficacy and safety data, go to http://productdata.aphis.usda.gov
For additional information, please see the product label.